Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a balance-training program help brain injury survivors walk safer and live better?

NCT ID NCT07696663

Disease control Sponsor: University of Castilla-La Mancha Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This trial tests whether a rehabilitation program that targets different aspects of balance can improve balance, mobility, walking, and quality of life in adults with acquired brain injury (from stroke, trauma, or other causes). Participants are randomly assigned to either the balance program or standard physiotherapy for 12 weeks. Researchers measure changes in balance, mobility, fall risk, and quality of life right after treatment and again 6 and 12 weeks later.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Multimodal Balance Rehabilitation Program
What this could lead to
If effective, this program could become a standard rehab approach to improve balance and reduce fall risk in people with brain injury.
What could go wrong
This is a small, early-stage trial with 68 participants, so results may not apply broadly. The program is intensive (5 sessions/week for 12 weeks), which may be hard to maintain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 68 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 to 65 years. * Diagnosis of acquired brain injury (stroke, traumatic brain injury, anoxic brain injury, brain tumor, or encephalitis). * At least 2 months since the brain injury. * Mini-Mental State Examination (MMSE) score greater than 24. * Modified Rankin Scale (mRS) score of 3 or lower. * Ability to walk independently or with an assistive device. * Clinical stability and ability to participate in a rehabilitation program. * Written informed consent signed by the participant. Exclusion Criteria: * Severe cognitive impairment (MMSE score of 24 or lower). * Severe functional dependence (mRS score greater than 3). * Unstable medical conditions that may interfere with participation. * Severe musculoskeletal, cardiovascular, or other conditions that prevent safe participation in the intervention. * Severe communication disorders that prevent understanding of study procedures. * Participation in another clinical trial that may interfere with the study results.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acquired brain injury are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acquired brain injury Balance disorders

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centro de Referencia Estatal de Atención al Daño Cerebral (CEADAC)

    Madrid, Madrid, 28031, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.